OPKO Health, Inc. announced today that its subsidiary and business unit, GeneDx, is entering into a collaboration with the Deciphering Developmental Disorder study led by the Wellcome Trust Sanger Institute. The Wellcome Trust Sanger Institute is a non-profit research institute that played a central role in the human genome project.